Your trusted source for investing success

Tag: jansen

Achillion Announces Results of Janssen’s Phase 2a Trial

Achillion Pharmaceuticals announced today that new interim results from a phase 2a study being conducted by Alios BioPharma, part of the Janssen Pharmaceutical Companies (Janssen), were published as part of the abstracts released for the upcoming European Association for the Study of the Liver (EASL) Special Conference.

Enter Your Log In Credentials
This setting should only be used on your home or work computer.


Privacy & Legal Policy

Privacy Policy

Investing News Network

Send this to a friend

I thought you might find this interesting:
BHP Delays Decision on Jansen Potash Mine